PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/307% below fair value
$16.18−0.06 (-0.37%)
Close on Nov 16, 2026Market cap $2.25BP/E –Yield 7.17%
Perrigo price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Perrigo's price to sales ratio was 0.6× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.3× to 1.3×, with a median of 0.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | +0.1 |
| 2025 | Dec 31, 2025 | 0.4× | −0.4 |
| 2024 | Dec 31, 2024 | 0.8× | −0.1 |
| 2023 | Dec 29, 2023 | 0.9× | −0.1 |
| 2022 | Dec 30, 2022 | 1.0× | −0.2 |
| 2021 | Dec 31, 2021 | 1.2× | −0.2 |
| 2020 | Dec 31, 2020 | 1.4× | −0.1 |
| 2019 | Dec 31, 2019 | 1.5× | +0.4 |
| 2018 | Dec 31, 2018 | 1.1× | −1.8 |
| 2017 | Dec 29, 2017 | 2.9× | +0.0 |
| 2016 | Dec 30, 2016 | 2.9× | −2.1 |
| 2015 | Dec 31, 2015 | 5.0× | −0.6 |
| 2014 | Dec 31, 2014 | 5.6× | +5.6 |
| 2013 | Dec 31, 2013 | 0.0× | – |
See a number that looks wrong?